“…The ability to monitor therapy in real time allows for strict control of the ablation area, and many previously inoperable lesions are now treatable with MRgLITT [3][4][5]. To date, MRgLITT has been successfully applied in the treatment of many intracranial pathologies, including glioblastoma multiforme (GBM) [6], ependymomas [6], epilepsy [7][8][9][10], metastatic tumours [6,11,12] and intractable pain [13]. Currently, there are two laser ablation systems approved for intracranial soft-tissue ablation: the Medtronic Visualase system (Medtronic Inc, Minneapolis, MN) and the Monteris NeuroBlate system (Monteris Medical, Plymouth, MN).…”